MYH2
Basic information
Region (hg38): 17:10521148-10549700
Previous symbols: [ "IBM3" ]
Links
Phenotypes
GenCC
Source:
- myopathy, proximal, and ophthalmoplegia (Strong), mode of inheritance: Semidominant
- hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome (Supportive), mode of inheritance: AD
- childhood-onset autosomal recessive myopathy with external ophthalmoplegia (Supportive), mode of inheritance: AR
- myopathy, proximal, and ophthalmoplegia (Strong), mode of inheritance: AR
- myopathy, proximal, and ophthalmoplegia (Strong), mode of inheritance: AR
- myopathy, proximal, and ophthalmoplegia (Strong), mode of inheritance: AD
- hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome (Limited), mode of inheritance: AD
- myopathy, proximal, and ophthalmoplegia (Definitive), mode of inheritance: Semidominant
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Congenital myopathy 6 with ophthalmoplegia | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Musculoskeletal | 11114175; 24193343 |
ClinVar
This is a list of variants' phenotypes submitted to
- Myopathy, proximal, and ophthalmoplegia (39 variants)
- not provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYH2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 14 | 243 | 10 | 267 | ||
missense | 639 | 650 | ||||
nonsense | 17 | 23 | ||||
start loss | 1 | |||||
frameshift | 21 | 29 | ||||
inframe indel | 11 | 11 | ||||
splice donor/acceptor (+/-2bp) | 20 | 23 | ||||
splice region | 36 | 37 | 73 | |||
non coding | 15 | 117 | 53 | 185 | ||
Total | 40 | 32 | 685 | 369 | 63 |
Highest pathogenic variant AF is 0.000158
Variants in MYH2
This is a list of pathogenic ClinVar variants found in the MYH2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-10521149-A-G | Myopathy, proximal, and ophthalmoplegia | Uncertain significance (Jan 13, 2018) | ||
17-10521229-G-T | Myopathy, proximal, and ophthalmoplegia | Benign/Likely benign (Aug 25, 2018) | ||
17-10521286-T-C | Myopathy, proximal, and ophthalmoplegia | Conflicting classifications of pathogenicity (Nov 20, 2023) | ||
17-10521301-T-A | MYH2-related disorder | Likely benign (Jul 22, 2020) | ||
17-10521305-T-G | Myopathy, proximal, and ophthalmoplegia | Uncertain significance (Oct 10, 2023) | ||
17-10521314-C-T | Myopathy, proximal, and ophthalmoplegia | Uncertain significance (Dec 03, 2023) | ||
17-10521315-G-A | Myopathy, proximal, and ophthalmoplegia | Uncertain significance (Nov 08, 2023) | ||
17-10521320-T-C | Myopathy, proximal, and ophthalmoplegia | Uncertain significance (Jul 22, 2019) | ||
17-10521326-C-T | not specified • Myopathy, proximal, and ophthalmoplegia • MYH2-related disorder | Benign/Likely benign (Aug 01, 2024) | ||
17-10521327-G-T | Myopathy, proximal, and ophthalmoplegia | Likely benign (Oct 29, 2021) | ||
17-10521329-A-C | Myopathy, proximal, and ophthalmoplegia | Uncertain significance (Aug 24, 2023) | ||
17-10521334-G-A | Myopathy, proximal, and ophthalmoplegia | Likely benign (Oct 09, 2023) | ||
17-10521341-T-C | Myopathy, proximal, and ophthalmoplegia | Uncertain significance (Nov 14, 2022) | ||
17-10521351-C-T | Myopathy, proximal, and ophthalmoplegia | Uncertain significance (Sep 02, 2020) | ||
17-10521353-A-G | Myopathy, proximal, and ophthalmoplegia | Uncertain significance (Oct 27, 2022) | ||
17-10521356-T-C | Myopathy, proximal, and ophthalmoplegia | Uncertain significance (Jan 29, 2024) | ||
17-10521357-C-T | Uncertain significance (May 08, 2020) | |||
17-10521358-A-G | Myopathy, proximal, and ophthalmoplegia | Likely benign (Dec 01, 2023) | ||
17-10521362-C-T | Myopathy, proximal, and ophthalmoplegia • Inborn genetic diseases | Uncertain significance (Mar 01, 2023) | ||
17-10521363-G-A | Myopathy, proximal, and ophthalmoplegia | Uncertain significance (Oct 03, 2023) | ||
17-10521369-C-T | Myopathy, proximal, and ophthalmoplegia • Inborn genetic diseases | Uncertain significance (Jun 07, 2024) | ||
17-10521370-G-A | Myopathy, proximal, and ophthalmoplegia | Likely benign (Jun 17, 2022) | ||
17-10521398-C-T | Myopathy, proximal, and ophthalmoplegia | Uncertain significance (Dec 23, 2023) | ||
17-10521399-G-A | Myopathy, proximal, and ophthalmoplegia | Uncertain significance (May 28, 2022) | ||
17-10521416-G-C | Myopathy, proximal, and ophthalmoplegia | Uncertain significance (Jun 25, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MYH2 | protein_coding | protein_coding | ENST00000245503 | 38 | 28810 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.67e-23 | 1.00 | 125566 | 0 | 182 | 125748 | 0.000724 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.97 | 826 | 1.00e+3 | 0.825 | 0.0000599 | 12909 |
Missense in Polyphen | 254 | 325.4 | 0.78059 | 4458 | ||
Synonymous | -0.693 | 404 | 387 | 1.04 | 0.0000228 | 3539 |
Loss of Function | 4.15 | 53 | 97.1 | 0.546 | 0.00000527 | 1244 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00123 | 0.00123 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000707 | 0.000707 |
Finnish | 0.00171 | 0.00171 |
European (Non-Finnish) | 0.000591 | 0.000571 |
Middle Eastern | 0.000707 | 0.000707 |
South Asian | 0.000882 | 0.000882 |
Other | 0.000490 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Muscle contraction. Required for cytoskeleton organization (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Myopathy, proximal, and ophthalmoplegia (MYPOP) [MIM:605637]: A muscular disorder characterized by mild-to- moderate muscle weakness, ophthalmoplegia, and contractures at birth in some patients. Muscle biopsies from patients show predominance of type 1 fibers and small or absent type 2A fibers. The disease is non-progressive or it progresses very slowly. Inheritance is autosomal dominant or recessive. {ECO:0000269|PubMed:11114175}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Tight junction - Homo sapiens (human);amb2 Integrin signaling;Alpha4 beta1 integrin signaling events
(Consensus)
Recessive Scores
- pRec
- 0.231
Intolerance Scores
- loftool
- 0.0360
- rvis_EVS
- -2.09
- rvis_percentile_EVS
- 1.57
Haploinsufficiency Scores
- pHI
- 0.892
- hipred
- Y
- hipred_score
- 0.632
- ghis
- 0.523
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.611
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Myh2
- Phenotype
Gene ontology
- Biological process
- muscle contraction;muscle filament sliding;Fc-gamma receptor signaling pathway involved in phagocytosis
- Cellular component
- cytosol;muscle myosin complex;myofibril;sarcomere;myosin filament;protein-containing complex
- Molecular function
- microfilament motor activity;protein binding;calmodulin binding;ATP binding;actin filament binding